Menopause Hormone Therapy Costs in Australia: PBS Listing and What You'll Actually Pay

Menopause hormone therapy (HRT) cost in Australia depends mainly on PBS listing status, which varies by specific brand, strength and formulation — not on how well a product works. Two women can walk out of two different pharmacies with two different HRT products and pay very different amounts, and the reason usually has nothing to do with which one "works better". It comes down to how each specific formulation and brand sits within the Pharmaceutical Benefits Scheme (PBS). This article looks at that cost mechanism specifically for HRT, without repeating the general PBS explainer already on this site — if you want the full background on how PBS listing works generally, read PBS and Non-PBS Medicines: Why Some of Our Range Isn't Subsidised. For the clinical side of HRT itself, see our menopause hormone therapy overview.

How PBS listing applies to HRT

Hormone therapy is not a single product with one fixed price — it's a category covering many different active ingredients, strengths, brands and delivery methods, each assessed separately for PBS subsidy. As with any medicine, a manufacturer has to apply for listing, and the Pharmaceutical Benefits Advisory Committee decides whether to approve it, sometimes with restrictions attached. Some HRT brands and strengths hold a general PBS listing, some are only subsidised for narrower circumstances, and others sit outside the PBS entirely and are dispensed as private prescriptions at the pharmacy's own price. This mix changes over time as listings are reviewed, so the only reliable way to know where a specific product currently sits is to check with your pharmacist or Services Australia when you have a script in hand — not to assume based on what a friend paid, or what applied last year.

Why cost varies so much between formulations

HRT comes in several delivery forms — oral tablets, transdermal patches, gels, and local vaginal preparations such as Premarin Vaginal Cream — and cost differences show up in more than one way. First, PBS status itself can differ between an oral product and a patch or cream containing a related hormone, even when they're used for related symptoms, because each is assessed on its own listing. Second, even within PBS-listed medicines, brand matters: different brands of an equivalent formulation aren't automatically priced or listed the same way. Third, for anything dispensed as a private prescription, the pharmacy sets its own retail price, and that price can vary meaningfully between pharmacies for the exact same product — it's genuinely worth comparing before committing to a long-term course. None of this reflects which formulation is more clinically appropriate for you; that's a separate conversation with your doctor based on your symptoms, not on price.

Questions worth asking before you start

A short conversation before your first script can save a surprise at the pharmacy counter later. Worth raising with your doctor or pharmacist:

• Is this specific brand and strength PBS-listed, or will I be paying a private prescription price?
• If it's private, roughly what should I expect to pay, and does that vary between pharmacies nearby?
• Is there a PBS-listed alternative formulation that might suit my symptoms, so I can weigh cost alongside the clinical differences?
• If I'm on a concession or DVA card, does that change anything for this particular product?
• If I need ongoing repeats, is the price likely to stay the same, or does it depend on stock and brand availability at the time?

Your pharmacist can usually answer the PBS and price questions on the spot, since it's drawn directly from the dispensing system rather than a general rule of thumb.

Getting a clear picture before you commit

Because HRT is often taken for months or longer, a price difference that looks small per script can add up over a course of treatment. It's entirely reasonable to ask about cost in the same conversation where you discuss which formulation suits your symptoms — doctors and pharmacists field this question regularly, and raising it early means cost doesn't become the deciding factor by accident partway through treatment. As with any Schedule 4 Prescription Only Medicine, menopause hormone therapy is only available after a doctor has assessed whether it's appropriate for you.

This article is general information, not medical or financial advice. PBS listings, prices and eligibility rules change over time and depend on the specific brand and formulation prescribed — confirm current costs and subsidy status with your pharmacist, doctor, or Services Australia before starting treatment.